TNFRSF4 and neoplasm: To define the mechanism underpinning the improved efficacy of BI 853520 in combination with anti-OX40, we next profiled the tumor immune cell infiltrate in response to treatment with either Vehicle, anti-OX40, BI 853520, or BI 853520 + anti-OX40.